BLACK CYBER WEEK! Publikacje i multimedia nawet do 80% taniej i darmowa dostawa od 350 zł! Sprawdź >
ABSTRACT
A patient with type 1 diabetes and Addison’s disease
Type 1 diabetes is a chronic autoimmune disease which often coexists with other endocrinopathies, including Addison’s disease (0.5-1%). Clinicians should be particularly mindful of adrenal insufficiency symptoms secondary to type 1 diabetes. Patients with Addison’s disease and type 1 diabetes are at high risk of acute life-threatening complications associated with both diseases. Long-term treatment of type 1 diabetes with co-existing primary adrenal insufficiency presents a considerable therapeutic challenge due to the simultaneous insulin and glucocorticoid deficiency. This often requires above-standard management of insulin therapy and hydrocortisone dosing regimen.
KEYWORDS: type 1 diabetes, hypoadrenalism, Addison’s disease.
Piśmiennictwo
1. Van den Driessche A, Eenkhoorn V, Van Gaal L, De Block C: Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth J Med 2009, 67(11):376-87
2. Gouveia S, Gomes L, Ribeiro C, Carrilho F. [Screening for autoimmune polyglandular syndrome in a cohort of patients with type 1 diabetes mellitus]. Arq Bras Endocrinol Metabol 2013,57(9):733-8
3. Chantzichristos D, Persson A, Eliasson B, Miftaraj M, Franzen S, Svensson AM, Johannsson G. Incidence, prevalence and seasonal onset variation of Addison’s disease among persons with type 1 diabetes mellitus: nationwide, matched cohort studies. Eur J Endocrinol 2018,178(1):113-20
4. Fichna M, Rogowicz-Frontczak A, Zurawek M, Fichna P, Gryczynska M, Zozulinska-Ziolkiewicz D, Ruchala M. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison’s disease. Endocrine 2016,53(1):249-57
5. Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA et al. Diagnosis and Treatment of Primary Adrenal Insufficiency. An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016,101(2):364-89
6. Chantzichristos D, Persson A, Miftaraj M, Eliasson B, Svensson AM, Johannsson G. Early Clinical Indicators of Addison Disease in Adults With Type 1 Diabetes: A Nationwide, Observational, Cohort Study. J Clin Endocrinol Metab 2019,104(4):1148-57
7. Mandadi S, Sattar S, Towfiq B, Bachuwa G. A case of nausea and vomiting to remember. BMJ Case Rep 2015, 2015
8. Elbelt U, Hahner S, Allolio B. Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy. Eur J Endocrinol 2009,160(6):919-24
9. Poland ApoD. 2019 Guidelines on the management of diabetic patients. Clinical Diabetology 2019,8(1)
10. Passanisi S, Timpanaro T, Lo Presti D, Caruso-Nicoletti M. Recurrent hypoglycaemia in type-1 diabetes mellitus may unravel the association with Addison’s disease: a case report. BMC Res Notes 2014,7:634
11. Newton CA, Sheehan E, Wyne K, Cusi K, Leey J, Ghayee HK. The Yin and Yang Between Plasma Glucose Levels and Cortisol Replacement Therapy in Schmidt’s Syndrome. J Investig Med High Impact Case Rep 2017,5(3):2324709617716203
12. Chantzichristos D, Persson A, Eliasson B, Miftaraj M, Franzen S, Bergthorsdottir R, Gudbjornsdottir S, Svensson AM, Johannsson G. Mortality in patients with diabetes mellitus and Addison’s disease: a nationwide, matched, observational cohort study. Eur J Endocrinol 2017,176(1):31-9
13. Trojanowska-Grigoriew M ML. Diabetic ketoacidosis without hyperglycemia as a complication of SGLT2 inhibitors treatment. Clinical Diabetology 2016,5(2):66-72
14. Matsuda E, Brennan P. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review. JBI Libr Syst Rev 2012,10(42 Suppl):1-10
15. Anderson SM, Buckingham BA, Breton MD, Robic JL, Barnett CL, Wakeman CA, Oliveri MC, Brown SA, Ly TT, Clinton PK et al. Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia. Diabetes Technol Ther 2019,21(6):356-63